Ralph K. Lindemann

2.8k citations

27 papers · 2.2k indexed · 1 hit paper · h-index 20

Co-authors: Ricky W. Johnstone Sebastian Wesselborg Gernot Stuhler Yi-jin Xiao Ingo B. Autenrieth Claus Belka Stefan Kröber Klaus Schulze‐Osthoff
Topics: Histone Deacetylase Inhibitors Research (7 papers)Cell death mechanisms and regulation (6 papers)TGF-β signaling in diseases (4 papers)
Cited by: Immunology Molecular Biology Oncology
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Germany Australia United States

In The Last Decade

Ralph K. Lindemann

27 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal

2003 756 citations Kirsten Lauber, Erwin Bohn et al. Cell profile →

Peers

Countries citing papers authored by Ralph K. Lindemann

Since Specialization

Citations

This map shows the geographic impact of Ralph K. Lindemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph K. Lindemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph K. Lindemann more than expected).

Fields of papers citing papers by Ralph K. Lindemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph K. Lindemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph K. Lindemann. The network helps show where Ralph K. Lindemann may publish in the future.

Co-authorship network of co-authors of Ralph K. Lindemann

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph K. Lindemann. A scholar is included among the top collaborators of Ralph K. Lindemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph K. Lindemann. Ralph K. Lindemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of extended treatment with IAP inhibitor xevinapant post radiotherapy (RT) on efficacy and the tumor microenvironment (TME) in preclinical models. 2023 ·Journal of Clinical Oncology ·(unknown),Feng Jiang,Jin Qi,Huakui Yu,Li-Ya Chiu,Bo Marelli,Hong Wang,(unknown),Molly H. Jenkins,Roberta Ferretti,Ralph K. Lindemann,Christina Esdar,Yan Lan	2
2	Exploiting the metabolic dependencies of the broad amino acid transporter SLC6A14 2020 ·Oncotarget ·Francesca R. Dejure,(unknown),Ralph K. Lindemann,Balca R. Mardin	5
3	Golgi stress mediates redox imbalance and ferroptosis in human cells 2018 ·Communications Biology ·Hamed Alborzinia,(unknown),Francesca R. Dejure,Mathieu Gendarme,Jannick Theobald,Stefan Wölfl,Ralph K. Lindemann,Jan H. Reiling	124
4	Image-based drug screen identifies HDAC inhibitors as novel Golgi disruptors synergizing with JQ1 2017 ·Molecular Biology of the Cell ·Mathieu Gendarme,Jan Baumann,(unknown),Ralph K. Lindemann,Jan H. Reiling	12
5	Secretory stressors induce intracellular death receptor accumulation to control apoptosis 2017 ·Cell Death and Disease ·Bram J. van Raam,(unknown),Ralph K. Lindemann,Jan H. Reiling	21
6	The mTORC1 Inhibitor Everolimus Prevents and Treats Eμ- Myc Lymphoma by Restoring Oncogene-Induced Senescence 2012 ·Cancer Discovery ·Meaghan Wall,Gretchen Poortinga,Kym L. Stanley,Ralph K. Lindemann,Michael Bots,Christopher J. Chan,Megan J. Bywater,Kathryn M. Kinross,Megan V. Astle,Kelly Waldeck,Katherine M. Hannan,Jake Shortt,Mark J. Smyth,Scott W. Lowe,Ross D. Hannan,Richard B. Pearson,Ricky W. Johnstone,Grant A. McArthur	52
7	The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy 2009 ·Blood ·Leigh Ellis,Michael Bots,Ralph K. Lindemann,Jessica E. Bolden,Andrea Newbold,Leonie A. Cluse,Clare L. Scott,Andreas Strasser,Peter Atadja,Scott W. Lowe,Ricky W. Johnstone	99
8	Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin 2008 ·Molecular Cancer Therapeutics ·Andrea Newbold,Ralph K. Lindemann,Leonie A. Cluse,Kate F. Whitecross,Anthony E. Dear,Ricky W. Johnstone	56
9	Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors 2008 ·Blood ·Kate F. Whitecross,Amber E. Alsop,Leonie A. Cluse,Adrian P. Wiegmans,Kellie-Marie Banks,Claudia P. Coomans,Melissa J. Peart,Andrea Newbold,Ralph K. Lindemann,Ricky W. Johnstone	71
10	Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist 2008 ·Proceedings of the National Academy of Sciences ·Ailsa J. Frew,Ralph K. Lindemann,Ben P. Martin,Christopher J. Clarke,Janelle Sharkey,(unknown),Kellie-Marie Banks,Nicole M. Haynes,Pradnya Gangatirkar,Kym L. Stanley,Jessica E. Bolden,Kazuyoshi Takeda,Hideo Yagita∥,J. Paul Secrist,Mark J. Smyth,Ricky W. Johnstone	118
11	The BH3-Only Protein Bid Is Dispensable for DNA Damage- and Replicative Stress-Induced Apoptosis or Cell-Cycle Arrest 2007 ·Cell ·Thomas Kaufmann,Lin Tai,Paul G. Ekert,David C.S. Huang,Fiona Norris,Ralph K. Lindemann,Ricky W. Johnstone,Vishva M. Dixit,Andreas Strasser	159
12	Response: Does Bid Play a Role in the DNA Damage Response? 2007 ·Cell ·Thomas Kaufmann,Lin Tai,Paul G. Ekert,David C.S. Huang,Fiona Norris,Ralph K. Lindemann,Ricky W. Johnstone,Vishva M. Dixit,Damien Arnoult,Andreas Strasser	7
13	Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma 2007 ·Proceedings of the National Academy of Sciences ·Ralph K. Lindemann,Andrea Newbold,Kate F. Whitecross,Leonie A. Cluse,Ailsa J. Frew,Leigh Ellis,Steven P. Williams,Adrian P. Wiegmans,Anthony E. Dear,Clare L. Scott,Marc Pellegrini,Andrew H. Wei,Victoria M. Richon,Paul A. Marks,Scott W. Lowe,Mark J. Smyth,Ricky W. Johnstone	166
14	Ets1 is an effector of protein kinase Cα in cancer cells 2004 ·Oncogene ·Martina Vetter,(unknown),Ralph K. Lindemann,(unknown),Sebastian Wesselborg,Christoph Thomssen,Jürgen Dittmer	19
15	Importance of Ets1 Proto-Oncogene for Breast Cancer Progression 2004 ·Zentralblatt für Gynäkologie ·(unknown),Marcus Vetter,(unknown),Ralph K. Lindemann,H Kölbl	6
16	A Central Role for Bid in Granzyme B-induced Apoptosis 2004 ·Journal of Biological Chemistry ·Nigel J. Waterhouse,Karin Sedelies,Kylie A. Browne,(unknown),Andrea Newbold,Vivien R. Sutton,Chris Clarke,Jane Oliaro,Ralph K. Lindemann,Phillip I. Bird,Ricky W. Johnstone,Joseph A. Trapani	106
17	Histone-Deacetylase Inhibitors for the Treatment of Cancer 2004 ·Cell Cycle ·Ralph K. Lindemann,Brian Gabrielli,Ricky W. Johnstone	130
18	Interfering with TGFbeta-induced Smad3 nuclear accumulation differentially affects TGFbeta-dependent gene expression. 2003 ·Molecular Cancer ·Ralph K. Lindemann,Alfred Nordheim,Jürgen Dittmer	16
19	Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signalbreakdown → 2003 ·Cell ·Kirsten Lauber,Erwin Bohn,Stefan Kröber,Yi-jin Xiao,(unknown),Ralph K. Lindemann,Patrizia Marini,(unknown),Anke Zobywalski,Shairaz Baksh,Yan Xu,Ingo B. Autenrieth,Klaus Schulze‐Osthoff,Claus Belka,Gernot Stuhler,Sebastian Wesselborg	756
20	Transforming Growth Factor β Regulates Parathyroid Hormone-related Protein Expression in MDA-MB-231 Breast Cancer Cells through a Novel Smad/Ets Synergism 2001 ·Journal of Biological Chemistry ·Ralph K. Lindemann,(unknown),Alfred Nordheim,Jürgen Dittmer	81

About Ralph K. Lindemann

Ralph K. Lindemann is a scholar working on Molecular Biology, Oncology and Cell Biology, having authored 27 papers that have together received 2.2k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (7 papers), Cell death mechanisms and regulation (6 papers) and TGF-β signaling in diseases (4 papers). The work is most often cited by research in Immunology (669 citations), Molecular Biology (1.5k citations) and Oncology (421 citations). Ralph K. Lindemann has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Ricky W. Johnstone, Sebastian Wesselborg, Gernot Stuhler, Yi-jin Xiao, Ingo B. Autenrieth, Claus Belka, Stefan Kröber, Klaus Schulze‐Osthoff, Erwin Bohn and Yan Xu. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact